EP2841125A1 - Bag with shrink-wrapped, flexurally rigid plastic part - Google Patents
Bag with shrink-wrapped, flexurally rigid plastic partInfo
- Publication number
- EP2841125A1 EP2841125A1 EP13718506.2A EP13718506A EP2841125A1 EP 2841125 A1 EP2841125 A1 EP 2841125A1 EP 13718506 A EP13718506 A EP 13718506A EP 2841125 A1 EP2841125 A1 EP 2841125A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- bag
- plastic part
- rigid plastic
- film
- ports
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004033 plastic Substances 0.000 title claims abstract description 97
- 229920003023 plastic Polymers 0.000 title claims abstract description 97
- 238000007789 sealing Methods 0.000 claims abstract description 40
- 239000000463 material Substances 0.000 claims abstract description 37
- 230000002093 peripheral effect Effects 0.000 claims abstract 4
- 238000003466 welding Methods 0.000 claims description 54
- 239000011888 foil Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 25
- 239000012530 fluid Substances 0.000 claims description 24
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 238000004026 adhesive bonding Methods 0.000 claims description 9
- 238000009423 ventilation Methods 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 claims description 3
- 238000002560 therapeutic procedure Methods 0.000 claims description 3
- 239000000385 dialysis solution Substances 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 3
- 238000000502 dialysis Methods 0.000 description 28
- 239000012141 concentrate Substances 0.000 description 26
- 235000008504 concentrate Nutrition 0.000 description 26
- 239000000243 solution Substances 0.000 description 23
- 238000011282 treatment Methods 0.000 description 18
- 239000007788 liquid Substances 0.000 description 15
- 238000011049 filling Methods 0.000 description 14
- 230000008569 process Effects 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 238000001631 haemodialysis Methods 0.000 description 6
- 230000000322 hemodialysis Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000013022 venting Methods 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000002615 hemofiltration Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000002706 hydrostatic effect Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002357 osmotic agent Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000005489 elastic deformation Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 235000014666 liquid concentrate Nutrition 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010971 suitability test Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1462—Containers with provisions for hanging, e.g. integral adaptations of the container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1666—Apparatus for preparing dialysates by dissolving solids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1668—Details of containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1668—Details of containers
- A61M1/167—Flexible packaging for solid concentrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1414—Hanging-up devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1414—Hanging-up devices
- A61M5/1417—Holders or handles for hanging up infusion containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D33/00—Details of, or accessories for, sacks or bags
- B65D33/02—Local reinforcements or stiffening inserts, e.g. wires, strings, strips or frames
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D33/00—Details of, or accessories for, sacks or bags
- B65D33/06—Handles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D33/00—Details of, or accessories for, sacks or bags
- B65D33/14—Suspension means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D33/00—Details of, or accessories for, sacks or bags
- B65D33/16—End- or aperture-closing arrangements or devices
- B65D33/1683—A pair of interconnecting rigid strips made of plastic material, e.g. one or both being provided with a handle or suspension means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/16—Holders for containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/30—Printed labels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1657—Apparatus for preparing dialysates with centralised supply of dialysate or constituent thereof for more than one dialysis unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/08—Supports for equipment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/52—Details
- B65D75/58—Opening or contents-removing devices added or incorporated during package manufacture
- B65D75/5861—Spouts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/52—Details
- B65D75/58—Opening or contents-removing devices added or incorporated during package manufacture
- B65D75/5861—Spouts
- B65D75/5872—Non-integral spouts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/52—Details
- B65D75/58—Opening or contents-removing devices added or incorporated during package manufacture
- B65D75/5861—Spouts
- B65D75/5872—Non-integral spouts
- B65D75/5877—Non-integral spouts connected to a planar surface of the package wall
Definitions
- the invention relates to the field of providing medical solutions, in particular solutions for infusion and kidney replacement therapy.
- the invention relates to a bag, in particular a multi-chamber bag for receiving concentrates with a circumferential seal and a receiving area of a rigid material, the addition and / or removal ports for liquids.
- Buffers for example, bicarbonate, acetate, lactate, etc.
- glucose or other osmotic agents
- glucose or other osmotic agents
- Acids or salts of acids for example HCl or CI " , acetic acid or
- Acetate, citric acid or citrate which may contribute to the neutralization of basic partial dialysis solutions or be present as counterions in the electrochemical equilibrium.
- the substances used for dialysis solution are generally not storable in a ready-mixed mixture, since the substances can cause mutual degradation.
- the required storage stability of a component may require storage conditions that leads to degradation for other components. For example, depending on the concentration in solution, glucose can only be stored for a long time in a certain acidic pH range without being subjected to excessive levels of undesired degradation processes. At the same time it is common in dialysis solution
- compositions, storage conditions and dosage forms of dialysis solutions or concentrates known that allow long storage.
- the division of the solution components into a combination of partial solutions or concentrates is known, so that only compatible components of a partial solution or a partial concentrate are stored together.
- a first partial solution comprising glucose, which takes over the function of the osmoticum, is conventionally stored at an acidic pH with further electrolytes, for example sodium, calcium, magnesium.
- Another basic or buffered partial solution is necessary in order to provide a physiological or at least ready for use mixed solution of the first part and the second part with the first acidic partial solution.
- the second part often consists of a solution or a concentrate of sodium bicarbonate and sodium chloride.
- the partial solutions or concentrates are presented in several containers or in several chambers of a container.
- the partial solutions or partial concentrates are separate, so that no mutual influence arises.
- the separated partial solutions or partial concentrates may be mixed with the addition of further aqueous components and provided for the treatment.
- partial solutions or partial concentrates are often mixed in the dialysis machine before and during the course of treatment and made into a finished dialysis solution.
- partial concentrates are used in solid or liquid form, which are present in individual containers and by connecting to the dialysis machine using a prepared Hydraulic system diluted, mixed and prepared to the final usable dialysis solution.
- dialysis solutions for hemodialysis are not prepared from concentrates during the course of the treatment, but the entire required volume of the dialysis solution is processed in a batch in a step upstream of the treatment.
- the batch is stored in a tank prepared to be connected to a dialysis machine.
- the tank is an integral part of a dialysis treatment unit or, in some cases, can be moved separately therefrom.
- Batch dialysis may thus have the advantage of being able to select the treatment site in a relatively location-independent manner by a single preparation of the batch.
- treatment stations can be used at various locations, without relying on a dialysis solution preparation unit or a water supply providing the necessary water to dilute the concentrates.
- the dialysis solution is mixed together at a dedicated facility of concentrates and stored in a mostly mobile tank.
- solution pouches that are commercially available and marketed in sterilized and ready-to-use form.
- mechanical stresses to which such bags are exposed on the distribution channels leading to complaints and unpleasant customer demands on the manufacturer.
- solution bags for peritoneal dialysis, hemodialysis and hemofiltration are commonly sold in sizes up to 5 liters.
- Solution bags with a larger capacity are difficult to deliver in ready-to-use form due to the transport logistics.
- the preparation of the solutions at the treatment and use site should be provided.
- the bags must be filled on site by a suitable liquid treatment plant and are within the hospital ward, to a certain extent also regional beyond, can be used.
- Such batch systems may require bag volumes of 30 to 120 liters.
- Such large-volume bags have a heavy load on welded sections, e.g. Welds or the welded ports on.
- these ports In order to be able to fill the bag via a port or to empty it via a port, these ports must be incorporated into the circumferential weld which fixes the film wall sections together and defines an internal volume of the bag.
- the ports have a passage opening which connects the interior of the bag with the outer region and can be flowed through by liquid.
- the outer end of the port is connected to other lines or connections of the bag system or the treatment station.
- welding ribs have been developed, which are aligned in the transverse direction to the extension direction of the through-opening of the ports and parallel to the weld seam of the film. In the manufacturing process, welding tools press the foils against these relatively thin welding ribs, which results locally in a very high contact pressure, which seals the weld seam.
- the tensile forces which affect the film walls due to gravity and possibly the internal hydrostatic pressure of a filled large-volume bag, can lead to a thinning of the film material.
- the foil wall gives way to the tensile forces by plastic or elastic deformation. Films can be designed to be stable despite these deformations; in particular, reference is made to WO 2011/128185, the contents of which are hereby incorporated by reference. It describes an elastically extensible film intended for the production of a large-volume bag. In the mechanical loading of welding sections on large-volume bags, the problem arises that the film can detach from its welded connection with the welding ribs of the welding boat by thinning. Such an effect may occur, in particular, because the film material has to be stretched over the arched welding ribs of the welding ship for the welding. By gravity or hydrostatic pressure of the filled bag additionally act foil-stretching forces on this weld.
- plastic parts have functional configurations, e.g. the access ports to the bag or a holding device to which the bag can be attached. These usage requirements also require the use of a mechanically stable, rigid material.
- EP 1 554 177 shows a method for sealingly welding hose ports between the foil walls of a solution bag.
- the font refers to the automatic picking up of the films, the insertion of the hose port and the welding. The problem of film stretching is discussed, however, the font shows no plastic part with a rigid material.
- EP 1 438 090 shows a bag with two access ports each opening into two separate inner regions of the bag.
- the bag has a holder consisting of simple receiving holes in the film material.
- Such a holding device is unsuitable for large-volume bags, since the film material can tear under the load of the filled bag.
- EP 1 642 614 B1 shows a concentrate bag with a plastic part which is functionally prepared for the addition / removal of liquid and assumes the holding function of the bag.
- the plastic part is sealingly welded to the foil walls via welding ribs.
- the bag receives a concentrate for producing a saturated solution, with which a dialysis fluid can be produced.
- the bag has only a low weight, even in the filled state, so that the problem, sealing function and support function of the weld zone of the welded hard part to ensure that does not come to fruition.
- No. 4,386,634 shows a large-volume container in which dry concentrates are prepared for the preparation of a dialysis solution. By supplying water, a liquid concentrate is prepared. The execution of the connection between film wall and hard part in fastening and sealing respects is not carried out in detail.
- the invention therefore an object of the invention to provide a bag which is mechanically strong in the supply and discharge lines, the bag also ensures high security for the sealing storage of the contents.
- the object is achieved by the subject matter of claim 1, a bag for containing a medical fluid, in particular a ready-to-use and / or used fluid, as found in extracorporeal blood treatment or kidney therapy, and by the subject-matter of claim 14, a method of manufacturing a bag, solved.
- Advantageous embodiments are represented by the features of the subclaims.
- the object is achieved by a rigid plastic part, which is connected separately from the boundary line with the foil walls.
- an inlet or outlet port is sealingly connected to the foil walls in a boundary line of the bag to be produced.
- a rigid plastic part is connected to the foil walls to form a mechanically resilient, aligned to the mechanical requirements of the bag connection zone.
- the bag according to the invention is constructed from foil wall sections.
- the walls of the bag are made entirely of film materials.
- a film material is characterized in the sense of the present teaching according to the invention in that it is a sheet-like, flexible, bendable and thin Plastic mass acts. Such sheet-like plastic materials are also encompassed by this terminology, which are in tubular form but can be flattened flat.
- Layer thicknesses of the films used for the article according to the invention are in the range of 50 to 500 ⁇ m, in particular 80 to 300 ⁇ m, depending on the embodiment also in the range of 100 to 250 ⁇ m.
- bag comprises collapsible containers which, when empty, are in a flattened form due to their own weight.
- the term also includes embodiments in which parts of the bag walls are made of a rigid material, as long as the overall character of the bags can be present in an empty state when empty.
- Characteristic of an embodiment according to the invention is that at least two films along a common boundary line form an inner enclosed volume and thus a bag.
- the boundary line may be a circumferential weld connecting two superimposed films.
- the boundary line can also be understood to consist only in sections of welds of the films and in other sections represents a folded film. This is the case in particular with tubular films. Such films are flattened, so that the two film tube halves lie one above the other and laterally form at least one film fold, which is also to be understood as a boundary line. In other areas, the loose ends of the films must be welded to obtain a closed bag. Access ports are incorporated between the slides.
- Hose pieces are inserted between two films and sealingly welded or glued in the common boundary line of the at least two films, as shown in EP 1 554 177.
- the ports can also be formed of rigid material, which include welding ribs and sealingly welded into the common boundary line of the films.
- the ports perform the function of providing access to the inner bag volume and the outer area. You can use other fluid handling agents For example, hoses, connectors and adapters connected to ensure a liquid supply or fluid removal.
- the bag according to the invention is characterized by at least one rigid plastic part incorporated into the bag, which is designed to receive the at least one feed / removal port integrally.
- rigid plastics are understood to mean thermoplastics which are used at a temperature below their Vicat temperature according to ISO 306.
- the rigid plastic part is connected to the bag or the foil walls, which means that the plastic part is welded, glued or connected to the films in a clamping action.
- Other attachment methods are equivalent in question, provided that they give a reliable connection in the mechanical connection to the foil walls.
- the bag can be connected via the incorporated plastic part with a fastening system or a holding system.
- connection between the rigid plastic part and the film wall of the bag must be so stable that the bag can be stored, for example, hanging or partially hanging.
- the connection between the rigid plastic part and the film wall of the bag must be so stable that the bag can be stored, for example, hanging or partially hanging.
- the connection between the rigid plastic part and foil walls then need not be worked out so precisely that it fulfills a sealing function and such tightness even with hanging storage and the tensile forces occurring would remain on these joints.
- the access port or other ports e.g. Venting ports incorporated by welding / gluing in the Um chargedsline. Over this Um drawnsline beyond projecting film sections can be welded to the rigid plastic part, clamped or glued so that sealing area and holding area attack on different zones of the bag.
- the rigid plastic part may comprise further functional units. It may be prepared to accommodate another access port to direct additional fluids to the interior of the bag, or to allow venting of the bag during fluid withdrawal or fluid filling.
- the access ports may be connected to e.g. Be equipped septa to be able to supply via syringes more components of the stored dialysis fluid.
- hydrophobic filters may be included in the access ports.
- welding methods are recommended as the preferred method for producing connections between the bag film and the ports. Although possibly similar bonding effects of the bag components could be achieved by gluing, the welds are preferred in terms of production technology.
- the welding of the tubular access ports in the Um chargedsline the bag is also preferably carried out by welding. Under welding methods, e.g. also to understand laser transmission welding processes, as e.g. mentioned in WO 2007/115803. It can also be used for welding the ports on the techniques of EP 1 554 177.
- the separation of the sealing welding of the ports and the welding of the functional rigid plastic part is especially relevant for bags with a large capacity.
- bags with a large capacity.
- the article according to the invention is therefore of particular relevance for bag sizes from two liters, as used, for example, in peritoneal dialysis. It is also relevant for bag sizes of 5 liters, which are used for dialysis or replacement fluids in peritoneal dialysis, hemodialysis or hemofiltration.
- bag sizes of up to 500 liters for a centralized supply of several dialysis treatment stations with dialysis fluid.
- bag volumes of up to 120 liters may be provided which are stored in a mobile tank to be connected to a dialysis treatment station.
- a bag with separate sealing of the sealing perimeter line and rigid plastic part is relevant to bags of 5 to 120 liters in size.
- the technical advantage of a separate welding of ports in the sealing Um chargedsline and receiving the ports in the separately welded rigid plastic part on a bag to bear when the bag is designed as a multi-chamber bag.
- one port can connect the inner region of a chamber to the outer region of the bag and thus a plurality of ports can be received by the welded-in, rigid plastic part.
- the chambers can be designed differently.
- a chamber is formed from an inner bag and a bag surrounding the inner bag forms two further chambers.
- the inner chamber or the outer chambers are further subdivided into compartments.
- the division of the compartments is done by boundary lines, which preferably consist of welds.
- the boundary lines consist at least in sections of peeled seams.
- peelable welded joints are to be understood as meaning joints of two joining partners which exert an adhesive effect on one another by heat treatment. In the present case, it is the joining partners by two opposite pieces of film of a bag, which are connected in the welding process with a welding bar by heat and contact pressure. The welding temperature determines the force with which the peel seam can be opened.
- a peel seam is to be understood as meaning an adhesive bond which can be released again by force, without a complete breakage of the film material taking place.
- peel compound can also be understood as meaning a compound which causes a partial delamination of a multilayer composite film by the action of force. In these cases it is important that the delamination tear does not cause complete breakage of the film material, which would render the bag unusable.
- the welded rigid plastic part is then preferably prepared to receive a plurality of ports, each connecting to a plurality of chambers or compartments of the bag.
- a plurality of ports is combined on a plastic part.
- the rigid plastic part can advantageously integrate further functions, e.g. For example, mounts for other items, e.g. Hoses be provided.
- portions of the plastic part may be separated from a line of weakness so that a portion of the plastic part may be broken to indicate that the bag has already been used.
- connection region between film walls and rigid plastic part it is not necessary for the connection region between film walls and rigid plastic part that this connection is made sealing.
- this connection eg welded, glued or clamped connection
- a Attachment of the bag can look like this, that the bag is stored hanging freely and worn over the welded plastic hard part.
- the plastic hard part is equipped with eyelets or a retaining rail, which are in engagement with complementary holding devices.
- a support apparatus is provided in addition to the holder on the welded rigid plastic part, which surrounds the bag at least in sections and supports to reduce the forces on the connection between film walls and rigid weld-in part.
- a film material is used for the bag in a large-volume design between 5 liters and 120 liters, which is elastically stretchable.
- the capacity of the bag increases with increasing filling similar to the inflation of a balloon.
- the use of such elastically stretchable film materials has the advantage for large-volume bags that with less film material, a large capacity of the filled bag can be provided. It is therefore possible that the bag in the unstretched state may have a volume of 5 liters and in the filled state comprises a volume of 60 liters.
- a film material which may preferably be used is described in WO 2011/128185, which is hereby incorporated by reference in its entirety. The subject invention becomes particularly important in the design of bags with stretchable film material.
- the stretching of the bag causes a thinning of the films.
- the choice of such film materials therefore requires higher precision in the design of the sealing weld. In that sense it will particularly difficult to design a weld simultaneously sealing and mechanically strong. According to the invention, therefore, welding areas which assume a sealing function are separated from welding areas which take over the mechanical support of the bag.
- the non-sealing weld area for other functions, as the already mentioned recording of the rigid plastic part.
- an information carrier by welding or gluing or clamping with the area which forms the connection between the rigid plastic part and foil sections.
- the information carrier may be formed as a printed piece of film that reflects information about the bag and the product contained therein.
- the information carrier may contain mechanically readable information that can be processed optically or magnetically or inductively via a reading device. Examples of optical information transmission are machine-readable bar codes or pixel codes, eg dot matrix codes, as well as color codings and the like. Magnetic transmission can be accomplished by reading information on magnetic strips.
- inductive information transmission according to RFID technology, which can also be connected in one embodiment on the information carrier with the bag.
- the information carrier is connected via detachable means to the bag and / or the non-sealing region between films and rigid plastic part.
- Detachable means may be perforated film sections, for example, which enable separation of the information carrier.
- the film-like information carrier is connected to the bag via a peel connection.
- the information carrier may also be arranged separately from the non-sealing connection region.
- the object according to the invention likewise comprises a method for producing a bag, wherein sealing welding areas and mechanically stable welding areas are present separately from one another.
- flat films are placed in parallel over each other and joined together along a perimeter line by welding or gluing.
- welding processes are used.
- a flattened film tube is used for the production of the bag, so that an upper film section is parallel to a lower section.
- the film tube now does not have to be welded or glued side.
- the film break formed in the flat state forms a portion of the Um chargedsline.
- the port accesses are positioned between the films to be bonded, preferably using hose ports.
- the hose ports are sealingly installed in the enclosure line.
- the inner bag has a round welding process, such as ultrasonic welding, mirror welding, contact welding or laser transmission welding, used around the port end 107b to make the sealing perimeter line with the machined ports.
- the rigid plastic part is connected to foil sections of the bag.
- an overhanging film section is used at the area where the ports are incorporated in the Um chargedsline.
- the plastic part is connected to the projecting film sections and this can be done using welding techniques, adhesive techniques or jamming. Preferred joining methods are welding methods.
- the plastic part may be in the immediate vicinity of the Um drawnsline in which the ports are sealed.
- the rigid plastic part may be prepared to receive the weld-in port.
- one or more ports can be inserted into hollow passages of the plastic part.
- the connection between the port and receiving the rigid plastic part can be done by gluing, heat blocking or welding, in particular laser transmission welding. Heat blocking is a bonding of the materials of Schlauchport and rigid plastic part by heat.
- the inclusion of the ports on the rigid plastic part also means that port and rigid plastic part form an integral component.
- the port sections themselves may consist of the material of the rigid plastic part.
- the port receiving area on the rigid plastic part may include a septum to form a pierceable delivery port.
- Another receiving area may include a filter, in particular a hydrophobic filter, to deaerate the bag during filling or removal of liquid germ-free.
- the filter is designed as a sterile filter, which effectively excludes the transport of microorganisms or endotoxins.
- the ports are first connected to the foil sections of the bag and subsequently to the receiving areas of the rigid plastic part or vice versa.
- the hose ports are connected in a first step with the receiving area on the rigid plastic part by gluing, blocking or welding.
- this assembled part is welded to the film material. The assembled part is positioned with the port ends between the superimposed films.
- the production step which connects the rigid plastic part with the films or it is first made the sealing Um chargedsline that surrounds the port or the sealing.
- the connecting regions between rigid plastic material and the films are not made sealingly.
- a sealing connection eg welded connection requires a high production accuracy.
- Film sections must be stretched exactly to seal encapsulated surfaces of welded hard parts or hose ports. For this reason, it is sufficient if the welded joint between rigid plastic part and film takes place only in those sections in which a rapid, without material expansion associated welding can take place. Therefore, preferably only flat and parallel aligned surfaces of film wall and plastic hard part are welded.
- the receiving areas of the ports in the plastic part are preferably excluded from the weld.
- inventive method can also be used for multi-chamber bag, especially for so-called "bag in bag” constructions in which an inner bag defines a first volume and an outer, the inner bag surrounding bag, another second volume and, optionally, a third volume
- bag in bag constructions in which an inner bag defines a first volume and an outer, the inner bag surrounding bag, another second volume and, optionally, a third volume
- the lower film also being understood as one half of a tubular film, and it is to be understood that two intertwined and flattened tubular films result in a sequence of four superimposed films.
- a flattened tubular film and two individual films would result in a sequence of four films, and in a further step, the ports are positioned between the films, such that they are already associated with the chamber portion of the finished bag can therefore be positioned between the first and second film or between the second and third film or between the third and fourth film.
- the formation of the sealing Um conductedslinien with sealingly enclosed ports, so that in this area the four films and the respective port are connected by the common Um chargedsline.
- an information carrier which contains information about the product in readable form or in machine-readable form.
- areas may be of the bag should not be printed with readable information, as filling the bag and stretching the slides would destroy the printed image. It has therefore proved necessary to attach the information carrier separately to the bag, so that the film stretching can not influence.
- an attached film containing the information for example in written form, as a bar code, as a dot matrix code, as a magnetic strip or RFID chip on the front and back can be provided with information.
- the connection to the Um chargedsline or the connection area between the plastic part and the film wall may be peelable or consist of an adhesive connection, so that the information carrier can be removed and inserted, for example, in a treatment protocol, a patient record.
- FIG. 1 shows a schematic view of a bag according to the invention, in particular of a multi-chamber bag, with ports sealingly received in the boundary line and a bending-resistant plastic part separately incorporated therein.
- Fig. 2 shows another view in a lateral perspective of the bag.
- the bag as shown schematically in Fig. 1, an upper outer wall 102a and a lower, not shown outer wall 102b, which are bounded by a common circumferential edge 108 and fluid-tightly connected.
- 102a and 102b are the upper and lower foils of a bag, the sealing surround lines 108 are formed by a common permanent weld.
- the bag has a first compartment A and another compartment C2 filled with concentrates for the preparation of dialysis fluids.
- the compartments A and C2 are along a closed Envelope line enclosed by a parting line 109a, which consists in the illustrated embodiment of an at least partially peelable parting line.
- the contents of compartments A and C1 are separated by the further dividing line 109b.
- the further separating line 109b may consist of a permanent welding line, a partially semipermanent welding line or a peel seam.
- the parting lines 109a and 109b are configured as peel seams and form a continuous integral construction of peel seam sections.
- connection port 106 connects the filling chamber 110 of the bag to the exterior of the bag via a first end inside the bag 106b and another end 106a outside the bag 101.
- Port 106 is preferably fluid tightly secured in the sealing perimeter line 108 to the weld zone 120 by welds.
- port 106 is received by the receiving portion 121 of the rigid plastic part 122 sealingly by welding, gluing or blocking.
- a means 106c for generating fluid turbulence of the incoming diluent may be configured as a turbulence generating nozzle or as a turbulence generating frit.
- port 106 consists of a tube which passes through the bag inside in its elongated extent. It is thus ensured in the filling process that when the bag is stored upright, for example by receiving the bag on a holding rail through the rigid plastic part 122, the bag is filled from below and the compartments A, B, C1, C2 in the sequence A at the same time with B, before C1 and C2 are opened by the internal filling pressure.
- Port 107 with a first end 107a outside the bag and another end 107b serves to recycle spent medical fluid, preferably used dialysis solution, into another chamber of the bag system.
- Port 107 is formed inside the bag as a hose and provided for hanging the bag, for example by Receiving the bag on a support rail of the rigid plastic part 122 to measure the bag along an elongated extent.
- the tube 107 penetrates the bag surround line 108a of the bag 101 and opens into another chamber, not shown.
- 111 may be a fluid-tight weld that secures the bag between the upper and lower bounding levels 102a and 102b and forms part of the welded perimeter line 108.
- the chamber is an enveloping container, preferably a bag, which is an integral part of the container system 101.
- the result is a "bag in bag” construction, in which the bag, which receives the ready-to-use liquid, from a bag that receives the used liquid is wrapped.
- Fig. 1 shows a second set of concentrate chambers B, C1, which are enclosed by a further parting line along a closed enclosure line 109c.
- Another partition line 109d separates the contents of the concentrate chambers B and C2.
- the lines 109c and 109d configured as peel seams, form an integral construction of peel seam sections that merge into one another.
- compartment B contains a glucose concentrate in powdered and / or anhydrous or in liquid form.
- Another compartment C1 contains a concentrate which is incompatible with the concentrate of the compartments A and B, ie tend to degrade or undesirable interaction would occur.
- the embodiment further shows an enclosure line 108, which preferably consists of a permanent weld. Additional permanent weld lines, sections 108a and 108b, limit the container contents or bag contents to form a sloping bottom of the interior.
- the design favors the turbulence of the incoming diluent by the fluid turbulence generating agent 106c and hence the dissolution process of the concentrates from the compartments A, B, C2, C1.
- Boundary lines 108c and 108d give the filled container, in particular bag, further stability in the filled state. This is particularly important for large-volume containers in which the internal pressure by the amounts involved can exert stress on the Um Publishedsline 108. Large-volume bags are to be understood in this sense as containers having a volume of 5 to 120 liters, 40 to 80 liters, in particular 60 liters ⁇ 15%.
- the fill chamber is filled via port 106 to dissolve the concentrates from compartments A, B, C1, C2.
- an external pumping means e.g. a tube roller pump or a diaphragm pump is taken from the contents for dialysis therapy or other processing processes.
- the withdrawn liquid it is returned via port 107 to the bag system, recessed portion 13 of the opposing films, such that the port end is in fluid communication with the volume of the outer enveloping bag.
- FIG. 1 further shows that the port ends 107a, 106a are connected to further fluid guidance means, in this case the tubes 140, 140a.
- the tubes in turn, have at their ends a connector part 123 intended to communicate the dialysis fluid in fluid communication with another fluid processing device, e.g. to bring a dialysis machine.
- 124 and 125 are designated ventilation ports.
- 125 may be related to the filling chamber 110 of the bag, with port 124 being related to the wrapping bag.
- port 124 When filling the chamber 110 of the bag 101 via the port 106, excess air can escape via the venting port 125.
- a necessary venting via the port 124 may take place.
- the vent ports 124, 125 penetrating the sealing perimeter line at the sealing locations 120c and 120b are received by the rigid plastic portion 122.
- the plastic part contains receiving areas for hydrophobic membranes 124a and 125a, so that the ventilation of the chambers can be carried out under low-germ conditions.
- passage openings in the film material of the inner bag are designated, which are intended to ensure that when filling the surrounding bag, not shown, with used liquid through port 107 and opening 113 of the surrounding bag is filled in a uniform manner.
- Fig. 2 shows a further illustration of the bag according to the invention.
- the outer bag is shown.
- the bag system of inner and outer bags is in a partially filled state.
- the illustration shows an upper foil 202c which, together with the rear foil 202d, not shown, and the joint along the perimeter line 208 define a closed volume of the surrounding bag.
- the accesses to the interior of the outer bag and to the interior of the inner bag (not shown) are made via the ports 206, 207, 225, 224.
- the ports 206, 207 represent fluid ports for filling and withdrawing liquid.
- the ports 225 and 224 are access points for low-germ ventilation during filling and emptying processes.
- Port 206 provides access to the inner bag
- port 207 provides access to the outer bag surrounding the inner bag.
- 225 represents a vent port for the inner bag and 224 is a port for venting the outer bag.
- the ports are incorporated at the locations 220, 220a, 220b, 220c, in the enclosure line 208 and received at the locations 221, 221a, 221b, 221c of the rigid plastic part.
- the rigid plastic part is connected to the film section 227 projecting beyond the surrounding line 108 by, for example, welding.
- the port receiving portions 221, 221a, 221b, 221c are excluded from the weld.
- Fig. 2 represent 229 hose clips for receiving the tubes, not shown, which connect to the port ends 207a, 206a.
- the plastic part 222 is produced in an injection molding process. It is therefore possible to integrate a plurality of functional units in a working process of injection molding on the plastic part. In particular, this also produces a cross-section through the longitudinal extent of the plastic part U-shaped shape of the plastic part.
- the plastic part is a U-shaped retaining rail, as indicated by 230.
- the holding rail can now be attached to a shape-complementary holding device and the bag can be secured in a receiving unit of a dialysis treatment station.
- an asymmetrical configuration of the plastic part can be achieved with a corresponding arrangement.
- FIG. 228, an information carrier is shown schematically in FIG.
- This information carrier consists of a film-like material and is connected via the connection zone 228a with the welding zone 226 only on one side.
- the film material can be printed and handled by only one-sided attachment.
- the connection zone 228a may be detachable, e.g. if 228a adhesive or blocking or Peelnahtitatien be selected.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Mechanical Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- External Artificial Organs (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL13718506T PL2841125T3 (en) | 2012-04-23 | 2013-04-18 | Bag with shrink-wrapped, flexurally rigid plastic part |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261636771P | 2012-04-23 | 2012-04-23 | |
DE102012007904.4A DE102012007904B4 (en) | 2012-04-23 | 2012-04-23 | Bag with connected rigid plastic part |
PCT/EP2013/001155 WO2013159883A1 (en) | 2012-04-23 | 2013-04-18 | Bag with shrink-wrapped, flexurally rigid plastic part |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2841125A1 true EP2841125A1 (en) | 2015-03-04 |
EP2841125B1 EP2841125B1 (en) | 2017-03-15 |
Family
ID=49289954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13718506.2A Active EP2841125B1 (en) | 2012-04-23 | 2013-04-18 | Bag with shrink-wrapped, flexurally rigid plastic part |
Country Status (8)
Country | Link |
---|---|
US (1) | US9198830B2 (en) |
EP (1) | EP2841125B1 (en) |
JP (1) | JP6368982B2 (en) |
CN (1) | CN104220107B (en) |
DE (1) | DE102012007904B4 (en) |
ES (1) | ES2628287T3 (en) |
PL (1) | PL2841125T3 (en) |
WO (1) | WO2013159883A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10987458B2 (en) | 2018-12-21 | 2021-04-27 | Fresenius Medical Care Holdings, Inc. | Method of using a medical fluid generating machine |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6049685B2 (en) | 2011-03-23 | 2016-12-21 | ネクステージ メディカル インコーポレイテッド | Peritoneal dialysis disposable unit, controller, peritoneal dialysis system |
US9861733B2 (en) | 2012-03-23 | 2018-01-09 | Nxstage Medical Inc. | Peritoneal dialysis systems, devices, and methods |
DE102013103336A1 (en) | 2013-04-03 | 2014-10-09 | B. Braun Avitum Ag | Device for identifying a dialyzer device or a component thereof, and sensor device usable therefor |
DE102013103335A1 (en) * | 2013-04-03 | 2014-10-09 | B. Braun Avitum Ag | System for detecting a state of a dialyzer device, and sensor device usable therefor |
JP2016055444A (en) * | 2014-09-05 | 2016-04-21 | セイコーエプソン株式会社 | Liquid storage body, liquid consumption device and electric connection body |
JP2016074124A (en) * | 2014-10-06 | 2016-05-12 | セイコーエプソン株式会社 | Liquid storage body and liquid supply device |
WO2018012542A1 (en) * | 2016-07-14 | 2018-01-18 | トタニ技研工業株式会社 | Bag making machine and method for manufacturing plastic bag |
FR3054126B1 (en) * | 2016-07-22 | 2019-07-26 | Sartorius Stedim Fmt Sas | BIOPHARMACEUTICAL CONTAINER, BIOPHARMACEUTICAL CONTAINER POUCH, METHOD FOR MANUFACTURING AND USE OF BIOPHARMACEUTICAL CONTAINER |
TWI584829B (en) * | 2016-08-23 | 2017-06-01 | 國立成功大學 | Moulding container for tissue engineering scaffolds |
DE102017202510A1 (en) | 2017-02-16 | 2018-08-16 | Eurozyto Gmbh | Container for providing patient-specific drugs |
CA3092575A1 (en) | 2018-02-28 | 2019-09-06 | Nxstage Medical, Inc. | Fluid preparation and treatment devices, methods, and systems |
US20210077351A1 (en) * | 2018-04-24 | 2021-03-18 | W. L. Gore & Associates, Inc. | Flexible container for storage and transport of biopharmaceuticals |
US11419791B2 (en) | 2018-07-05 | 2022-08-23 | Fresenius Medical Care Holdings, Inc. | Flexible container systems and nozzles, and related methods |
US11065095B2 (en) | 2018-07-06 | 2021-07-20 | Instant Systems, Inc. | Sample container with peelable seal and access port |
US20200115128A1 (en) * | 2018-10-10 | 2020-04-16 | David S. Smith America, Inc., Dba, Worldwide Dispensers | Multi-Port Quick Disconnect Spout |
CN111544296B (en) * | 2020-06-18 | 2024-03-12 | 四川省人民医院 | Light energy storage bag for blood products |
US11890819B2 (en) | 2021-03-24 | 2024-02-06 | Instant Systems, Inc. | Multi-chamber container for biological materials and compounded pharmaceuticals |
US11950591B2 (en) | 2021-06-11 | 2024-04-09 | Instant Systems, Inc. | Container with biological materials having multiple sealed portions |
WO2023031910A1 (en) * | 2021-09-02 | 2023-03-09 | Rambam Medtech Ltd. | Closed system for sterile drug preparation and administration |
WO2023205033A1 (en) * | 2022-04-18 | 2023-10-26 | Instant Systems, Inc. | Container with internal port |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3371897A (en) * | 1965-07-22 | 1968-03-05 | Bard Inc C R | Drain bag support assembly |
US3558039A (en) * | 1968-08-07 | 1971-01-26 | Ctp Ind Inc | Carrying bag |
US3865165A (en) * | 1973-10-25 | 1975-02-11 | Daniel S Glass | Universal faced body fluid drainage bag with universal drainage means |
US3985135A (en) * | 1975-03-31 | 1976-10-12 | Baxter Laboratories, Inc. | Dual chamber reservoir |
US4365629A (en) * | 1979-05-29 | 1982-12-28 | Hedbergska Stiftelsen | Platelet freezing bag |
US4312352A (en) * | 1980-01-29 | 1982-01-26 | C. R. Bard, Inc. | Hanger, hook and handle assembly for urinary drainage bag |
US4386634A (en) | 1980-10-10 | 1983-06-07 | Renal Systems, Inc. | Proportioning system |
US4432763A (en) * | 1982-05-10 | 1984-02-21 | The Kendall Company | Fluid delivery system and method |
US4562984A (en) * | 1983-08-08 | 1986-01-07 | Sherwood Medical Company | Drainage bag support |
US4619648A (en) * | 1984-12-20 | 1986-10-28 | The Kendall Company | Connection apparatus for side connection to fluid collection bag |
US4743236A (en) * | 1985-05-17 | 1988-05-10 | Plastronics, Inc. | Combination urine meter and urinary drainage bag and the method of use |
US4869398A (en) * | 1986-11-25 | 1989-09-26 | Life Technologies, Inc. | Liquid container delivery and storage system |
US4994021A (en) * | 1988-11-15 | 1991-02-19 | Baxter International Inc. | Apparatus and method for collecting and freezing blood plasma |
ES2070005T3 (en) | 1991-05-08 | 1995-05-16 | Baxter Int | CONTAINER FOR IRRADIATION OF BLOOD PRODUCTS. |
US6428518B1 (en) * | 1999-11-05 | 2002-08-06 | Tandem Medical | Medication delivery container |
US6684646B2 (en) * | 2001-05-22 | 2004-02-03 | Integrated Biosystems, Inc. | Systems and methods for freezing, storing and thawing biopharmaceutical material |
DE10152105A1 (en) | 2001-10-23 | 2003-05-08 | Fresenius Medical Care De Gmbh | Container for use in dialysis |
ES2265057T3 (en) * | 2001-11-01 | 2007-02-01 | Integrated Biosystems Inc. | SYSTEMS AND PROCEDURES TO FREEZE, STORE AND DEFROST BIOPHARMACEUTICAL MATERIAL. |
LT2308548T (en) | 2002-03-11 | 2016-10-10 | Fresenius Medical Care Deutschland Gmbh | Connector, container with such a connector and fluid preparation device with a mating connector for such a container |
JP3932427B2 (en) * | 2002-08-23 | 2007-06-20 | 株式会社大塚製薬工場 | Manufacturing method of medical multi-chamber container |
ES2344786T3 (en) | 2002-10-14 | 2010-09-07 | Fresenius Medical Care Deutschland Gmbh | DEVICE AND PROCEDURE FOR THE HANDLING OF TWO SUPERPOSED SHEETS AND BAG MANUFACTURED WITH THE PROCEDURE BEFORE MENTIONED. |
US20060272976A1 (en) * | 2003-07-01 | 2006-12-07 | Asteres, Inc. | Container for use in a random access and random load dispensing unit |
WO2007063777A1 (en) * | 2005-11-29 | 2007-06-07 | Otsuka Pharmaceutical Factory, Inc. | Method of reinforcing soft sealing part of multicell container for medical use |
EP2444237B1 (en) | 2006-04-06 | 2018-06-06 | Fresenius Medical Care Deutschland GmbH | Transmission laser welding method for joining plastic moulded articles and welded joint |
ES2396907T3 (en) * | 2006-06-02 | 2013-03-01 | Fresenius Medical Care Deutschland Gmbh | Container filled with a liquid concentrate to prepare a dialysis liquid |
EP3025738A1 (en) * | 2006-06-15 | 2016-06-01 | Metpro AB | Container, system and method for providing a solution |
US8430855B2 (en) * | 2006-12-06 | 2013-04-30 | Medline Industries, Inc. | Fluid collection system and methods of using same |
EP2091497B1 (en) * | 2006-12-07 | 2015-04-22 | Gambro Lundia AB | Multicompartment container |
CN101849186B (en) * | 2007-10-19 | 2013-05-22 | 美国中西医疗技术有限责任公司 | Method and apparatus for identifying and tracking biological fluid |
FR2925341A1 (en) * | 2007-12-20 | 2009-06-26 | Gambro Lundia Ab | APPARATUS FOR THE EXTRACORPOREAL TREATMENT OF BLOOD OR PLASMA RECEIVING MULTIPLE ARTICLES FOR SINGLE USE |
US20110052101A1 (en) * | 2008-06-30 | 2011-03-03 | Michael Herbert Paulse | Apparatus for hanging a resealable bag |
JP5262407B2 (en) * | 2008-08-05 | 2013-08-14 | 藤森工業株式会社 | Multi-layer liquid container |
IT1395490B1 (en) * | 2009-09-02 | 2012-09-28 | Aea Srl | TAKING BAG OF A BAG FOR PHARMACEUTICALS |
WO2011070329A1 (en) * | 2009-12-11 | 2011-06-16 | Paradigm Design Limited | A sterilisation pouch |
DE102009058445B4 (en) * | 2009-12-16 | 2016-09-15 | Fresenius Medical Care Deutschland Gmbh | Multi-chamber bags |
DE102010014785A1 (en) | 2010-04-13 | 2011-10-13 | Fresenius Medical Care Deutschland Gmbh | Multilayer film, use of a multilayer film and method for producing a multilayer film |
-
2012
- 2012-04-23 DE DE102012007904.4A patent/DE102012007904B4/en active Active
-
2013
- 2013-04-18 ES ES13718506.2T patent/ES2628287T3/en active Active
- 2013-04-18 JP JP2015507412A patent/JP6368982B2/en active Active
- 2013-04-18 EP EP13718506.2A patent/EP2841125B1/en active Active
- 2013-04-18 CN CN201380021196.6A patent/CN104220107B/en active Active
- 2013-04-18 PL PL13718506T patent/PL2841125T3/en unknown
- 2013-04-18 WO PCT/EP2013/001155 patent/WO2013159883A1/en active Application Filing
- 2013-04-22 US US13/867,322 patent/US9198830B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10987458B2 (en) | 2018-12-21 | 2021-04-27 | Fresenius Medical Care Holdings, Inc. | Method of using a medical fluid generating machine |
Also Published As
Publication number | Publication date |
---|---|
JP2015519929A (en) | 2015-07-16 |
WO2013159883A1 (en) | 2013-10-31 |
US9198830B2 (en) | 2015-12-01 |
DE102012007904A1 (en) | 2013-10-24 |
CN104220107A (en) | 2014-12-17 |
US20130281964A1 (en) | 2013-10-24 |
DE102012007904B4 (en) | 2015-08-27 |
PL2841125T3 (en) | 2017-08-31 |
CN104220107B (en) | 2017-03-29 |
ES2628287T3 (en) | 2017-08-02 |
JP6368982B2 (en) | 2018-08-08 |
EP2841125B1 (en) | 2017-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2841125B1 (en) | Bag with shrink-wrapped, flexurally rigid plastic part | |
EP2838580B1 (en) | Bag with flow equalisation | |
EP2696910B1 (en) | Multi-chamber container for producing medical solutions | |
EP2726121B1 (en) | Container, use, dialysis device or preparation unit and method for producing a concentrate | |
DE102009058445B4 (en) | Multi-chamber bags | |
EP0697220B1 (en) | Flexible packaging unit for a dry concentrate for the preparation of a dialysate concentrate | |
EP0161471B1 (en) | Holder for a fluid containing bicarbonate | |
DE112017000470T5 (en) | Product bag for sterile solution | |
EP0535688A1 (en) | Packaging system with spike | |
EP2320851B1 (en) | Method and device for transferring a substance between closed systems | |
EP2167011A1 (en) | Multi-chamber bag for use with enteral nutrition | |
EP1458433B1 (en) | Container containing at least two solid materials, and use thereof | |
EP0665026A2 (en) | Dialysis apparatus | |
DE10041295A1 (en) | Method for producing a two-chamber arrangement and a two-chamber arrangement | |
DE102013207567A1 (en) | Biocontainer-transfer assembly | |
DE202017107087U1 (en) | Container for providing patient-specific drugs | |
DE3021911C2 (en) | ||
DE3700713C2 (en) | ||
EP0315740A2 (en) | System for preservation, preparation and administration of infusion solutions for parenteral nutrition | |
WO2010023564A2 (en) | Device and method for transferring a substance from a closed source system into a target system | |
WO2023148320A1 (en) | Infusion bag, and method for producing same | |
EP3755392A1 (en) | Vehicle for providing a dialysis solution | |
DE3920775A1 (en) | Solns. of active agents with carrier solns. - obtd. by using two bags for storage, both with fillers and connector | |
DE4003146A1 (en) | Collapsible bottle for liquid nourishment to feed patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20141124 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20160330 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20161006 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 874906 Country of ref document: AT Kind code of ref document: T Effective date: 20170415 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502013006662 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20170315 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170616 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170615 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2628287 Country of ref document: ES Kind code of ref document: T3 Effective date: 20170802 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170615 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170715 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170717 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502013006662 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 |
|
26N | No opposition filed |
Effective date: 20171218 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170430 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170430 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170418 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20170430 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170418 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 874906 Country of ref document: AT Kind code of ref document: T Effective date: 20180418 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20130418 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180418 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170315 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20220324 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230321 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20230323 Year of fee payment: 11 Ref country code: SE Payment date: 20230327 Year of fee payment: 11 Ref country code: IT Payment date: 20230322 Year of fee payment: 11 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230602 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20230502 Year of fee payment: 11 Ref country code: DE Payment date: 20230321 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240320 Year of fee payment: 12 |